Annual Operating Profit
-$60.12 M
-$17.32 M-40.48%
December 1, 2024
Summary
- As of March 12, 2025, ALDX annual operating income is -$60.12 million, with the most recent change of -$17.32 million (-40.48%) on December 1, 2024.
- During the last 3 years, ALDX annual operating profit has fallen by -$3.90 million (-6.93%).
- ALDX annual operating profit is now -5295.53% below its all-time high of -$1.11 million, reached on December 31, 2012.
Performance
ALDX Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Profit
-$16.58 M
-$440.20 K-2.73%
December 1, 2024
Summary
- As of March 12, 2025, ALDX quarterly operating income is -$16.58 million, with the most recent change of -$440.20 thousand (-2.73%) on December 1, 2024.
- Over the past year, ALDX quarterly operating profit has dropped by -$10.48 million (-171.87%).
- ALDX quarterly operating profit is now -14142.10% below its all-time high of -$116.40 thousand, reached on December 31, 2012.
Performance
ALDX Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Operating Profit
-$60.12 M
-$10.48 M-21.11%
December 1, 2024
Summary
- As of March 12, 2025, ALDX TTM operating income is -$60.12 million, with the most recent change of -$10.48 million (-21.11%) on December 1, 2024.
- Over the past year, ALDX TTM operating profit has dropped by -$17.32 million (-40.48%).
- ALDX TTM operating profit is now -51546.99% below its all-time high of -$116.40 thousand, reached on December 31, 2012.
Performance
ALDX TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
ALDX Operating Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -40.5% | -171.9% | -40.5% |
| 3 y3 years | -6.9% | -7.6% | -6.9% |
| 5 y5 years | -6.4% | -29.2% | -6.4% |
ALDX Operating Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -40.5% | +4.1% | -171.9% | +7.9% | -69.9% | +7.6% |
| 5 y | 5-year | -73.4% | +4.1% | -171.9% | +7.9% | -73.4% | +7.6% |
| alltime | all time | -5295.5% | +4.1% | <-9999.0% | +13.0% | <-9999.0% | +7.6% |
Aldeyra Therapeutics Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$60.12 M(+40.5%) | -$16.58 M(+2.7%) | -$60.12 M(+21.1%) |
| Sep 2024 | - | -$16.14 M(-10.4%) | -$49.64 M(+15.3%) |
| Jun 2024 | - | -$18.01 M(+91.7%) | -$43.05 M(+21.7%) |
| Mar 2024 | - | -$9.39 M(+54.1%) | -$35.38 M(-17.3%) |
| Dec 2023 | -$42.79 M(-31.7%) | -$6.10 M(-36.2%) | -$42.79 M(-15.1%) |
| Sep 2023 | - | -$9.55 M(-7.7%) | -$50.39 M(-9.4%) |
| Jun 2023 | - | -$10.34 M(-38.4%) | -$55.63 M(-11.7%) |
| Mar 2023 | - | -$16.80 M(+22.7%) | -$63.00 M(+0.5%) |
| Dec 2022 | -$62.68 M(+11.5%) | -$13.70 M(-7.4%) | -$62.68 M(-2.7%) |
| Sep 2022 | - | -$14.78 M(-16.5%) | -$64.39 M(-1.0%) |
| Jun 2022 | - | -$17.71 M(+7.5%) | -$65.04 M(+5.1%) |
| Mar 2022 | - | -$16.48 M(+7.0%) | -$61.87 M(+10.1%) |
| Dec 2021 | -$56.22 M(+62.2%) | -$15.40 M(-0.2%) | -$56.22 M(+11.7%) |
| Sep 2021 | - | -$15.44 M(+6.2%) | -$50.35 M(+16.3%) |
| Jun 2021 | - | -$14.54 M(+34.3%) | -$43.30 M(+20.7%) |
| Mar 2021 | - | -$10.83 M(+13.6%) | -$35.86 M(+3.4%) |
| Dec 2020 | -$34.67 M(-38.6%) | -$9.53 M(+13.6%) | -$34.67 M(-8.7%) |
| Sep 2020 | - | -$8.39 M(+18.1%) | -$37.96 M(-21.9%) |
| Jun 2020 | - | -$7.11 M(-26.3%) | -$48.64 M(-12.1%) |
| Mar 2020 | - | -$9.64 M(-24.9%) | -$55.31 M(-2.1%) |
| Dec 2019 | -$56.51 M(+42.3%) | -$12.83 M(-32.7%) | -$56.51 M(+3.2%) |
| Sep 2019 | - | -$19.06 M(+38.3%) | -$54.77 M(+17.4%) |
| Jun 2019 | - | -$13.78 M(+27.2%) | -$46.66 M(+11.0%) |
| Mar 2019 | - | -$10.83 M(-2.4%) | -$42.04 M(+5.9%) |
| Dec 2018 | -$39.70 M | -$11.10 M(+1.4%) | -$39.70 M(+11.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2018 | - | -$10.95 M(+19.4%) | -$35.65 M(+20.0%) |
| Jun 2018 | - | -$9.17 M(+7.9%) | -$29.72 M(+14.8%) |
| Mar 2018 | - | -$8.49 M(+20.5%) | -$25.88 M(+15.1%) |
| Dec 2017 | -$22.49 M(+20.3%) | -$7.05 M(+40.5%) | -$22.49 M(+11.9%) |
| Sep 2017 | - | -$5.02 M(-5.9%) | -$20.09 M(+1.2%) |
| Jun 2017 | - | -$5.33 M(+4.6%) | -$19.86 M(+5.5%) |
| Mar 2017 | - | -$5.10 M(+9.5%) | -$18.82 M(+0.7%) |
| Dec 2016 | -$18.70 M(+55.9%) | -$4.65 M(-2.6%) | -$18.69 M(+1.7%) |
| Sep 2016 | - | -$4.78 M(+11.2%) | -$18.38 M(+8.5%) |
| Jun 2016 | - | -$4.30 M(-13.5%) | -$16.94 M(+14.1%) |
| Mar 2016 | - | -$4.97 M(+14.5%) | -$14.85 M(+23.8%) |
| Dec 2015 | -$11.99 M(+64.9%) | -$4.34 M(+30.0%) | -$11.99 M(+19.2%) |
| Sep 2015 | - | -$3.34 M(+51.4%) | -$10.06 M(+15.8%) |
| Jun 2015 | - | -$2.20 M(+4.5%) | -$8.69 M(+6.9%) |
| Mar 2015 | - | -$2.11 M(-12.5%) | -$8.13 M(+11.9%) |
| Dec 2014 | -$7.27 M(+97.8%) | -$2.41 M(+22.5%) | -$7.27 M(+19.3%) |
| Sep 2014 | - | -$1.97 M(+19.5%) | -$6.09 M(+15.2%) |
| Jun 2014 | - | -$1.65 M(+32.3%) | -$5.29 M(+14.3%) |
| Mar 2014 | - | -$1.24 M(+1.0%) | -$4.63 M(+25.9%) |
| Dec 2013 | -$3.68 M(+230.0%) | -$1.23 M(+5.7%) | -$3.68 M(+43.6%) |
| Sep 2013 | - | -$1.17 M(+18.3%) | -$2.56 M(+83.7%) |
| Jun 2013 | - | -$985.70 K(+238.1%) | -$1.39 M(+241.7%) |
| Mar 2013 | - | -$291.50 K(+150.4%) | -$407.90 K(+250.4%) |
| Dec 2012 | -$1.11 M(-47.2%) | -$116.40 K | -$116.40 K |
| Dec 2011 | -$2.11 M | - | - |
FAQ
- What is Aldeyra Therapeutics annual operating income?
- What is the all time high annual operating profit for Aldeyra Therapeutics?
- What is Aldeyra Therapeutics annual operating profit year-on-year change?
- What is Aldeyra Therapeutics quarterly operating income?
- What is the all time high quarterly operating profit for Aldeyra Therapeutics?
- What is Aldeyra Therapeutics quarterly operating profit year-on-year change?
- What is Aldeyra Therapeutics TTM operating income?
- What is the all time high TTM operating profit for Aldeyra Therapeutics?
- What is Aldeyra Therapeutics TTM operating profit year-on-year change?
What is Aldeyra Therapeutics annual operating income?
The current annual operating profit of ALDX is -$60.12 M
What is the all time high annual operating profit for Aldeyra Therapeutics?
Aldeyra Therapeutics all-time high annual operating income is -$1.11 M
What is Aldeyra Therapeutics annual operating profit year-on-year change?
Over the past year, ALDX annual operating income has changed by -$17.32 M (-40.48%)
What is Aldeyra Therapeutics quarterly operating income?
The current quarterly operating profit of ALDX is -$16.58 M
What is the all time high quarterly operating profit for Aldeyra Therapeutics?
Aldeyra Therapeutics all-time high quarterly operating income is -$116.40 K
What is Aldeyra Therapeutics quarterly operating profit year-on-year change?
Over the past year, ALDX quarterly operating income has changed by -$10.48 M (-171.87%)
What is Aldeyra Therapeutics TTM operating income?
The current TTM operating profit of ALDX is -$60.12 M
What is the all time high TTM operating profit for Aldeyra Therapeutics?
Aldeyra Therapeutics all-time high TTM operating income is -$116.40 K
What is Aldeyra Therapeutics TTM operating profit year-on-year change?
Over the past year, ALDX TTM operating income has changed by -$17.32 M (-40.48%)